Nucleic Acid Testing Market Report: Trends, Forecast and Competitive Analysis to 2030

Nucleic Acid Testing Market Report: Trends, Forecast and Competitive Analysis to 2030

Nucleic Acid Testing Trends and Forecast

The future of the global nucleic acid testing market looks promising with opportunities in the hospital & clinic, pathology laboratory, and academic & research organization markets. The global nucleic acid testing market is expected to reach an estimated $6.7 billion by 2030 with a CAGR of 11.2% from 2024 to 2030. The major drivers for this market are rising need for precise and quick diagnostic tests, increasing need for nucleic acid test kits from blood banks and transfusion centers, and escalating incidence of cancer, genetic disorders, and infectious diseases.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Nucleic Acid Testing by Segment

The study includes a forecast for the global nucleic acid testing by product type, indication, end use, and region.

Nucleic Acid Testing Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Polymerase Chain Reaction
• Ligase Chain Reaction
• Transcription–Mediated Amplification
• Whole Genome Sequencing
• Others

Nucleic Acid Testing Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

• Infectious Disease
• Cancer
• Forensic Testing
• Personalized Medicine
• Others

Nucleic Acid Testing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Pathology Laboratories
• Academic & Research Organization
• Others

Nucleic Acid Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Nucleic Acid Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies nucleic acid testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nucleic acid testing companies profiled in this report include-

• F. Hoffmann-La Roche
• Becton and Dickinson
• Danaher
• Abbott Laboratories
• Illumina
• Siemens Healthineers
• bioMérieux

Nucleic Acid Testing Market Insights

Lucintel forecasts that infectious disease will remain the largest segment due to considerable use of nucleic acid testing kit for genotype and subtype identification that aids in determining viral load.

North America is expected to witness highest growth over the forecast period due to increasing prevalence of infectious diseases among population and presence of strong government support for nucleic acid testing research and development in the region.

Features of the Global Nucleic Acid Testing Market

Market Size Estimates: Nucleic acid testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Nucleic acid testing market size by product type, indication, end use, and region in terms of value ($B).

Regional Analysis: Nucleic acid testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, indications, end uses, and regions for the nucleic acid testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nucleic acid testing market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q.1 What is the nucleic acid testing market size?

Answer: The global nucleic acid testing market is expected to reach an estimated $6.7 billion by 2030.

Q.2 What is the growth forecast for nucleic acid testing market?

Answer: The global nucleic acid testing market is expected to grow with a CAGR of 11.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the nucleic acid testing market?

Answer: The major drivers for this market are rising need for precise and quick diagnostic tests, increasing need for nucleic acid test kits from blood banks and transfusion centers, and escalating incidence of cancer, genetic disorders, and infectious diseases.

Q4. What are the major segments for nucleic acid testing market?

Answer: The future of the nucleic acid testing market looks promising with opportunities in the hospital & clinic, pathology laboratory, and academic & research organization markets.

Q5. Who are the key nucleic acid testing market companies?

Answer: Some of the key nucleic acid testing companies are as follows:

• F. Hoffmann-La Roche
• Becton and Dickinson
• Danaher
• Abbott Laboratories
• Illumina
• Siemens Healthineers
• bioMérieux

Q6. Which nucleic acid testing market segment will be the largest in future?

Answer: Lucintel forecasts that infectious disease will remain the largest segment due to considerable use of nucleic acid testing kit for genotype and subtype identification that aids in determining viral load.

Q7. In nucleic acid testing market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to increasing prevalence of infectious diseases among population and presence of strong government support for nucleic acid testing research and development in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the nucleic acid testing market by product type (polymerase chain reaction, ligase chain reaction, transcription–mediated amplification, whole genome sequencing, and others), indication (infectious disease, cancer, forensic testing, personalized medicine, and others), end use (hospitals & clinics, pathology laboratories, academic & research organization, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Please note: It will take 2-3 business days to deliver the report upon receipt the order.